Latest animal models for anti-HIV drug discovery-Reference-Cited by-同舟云学术

Latest animal models for anti-HIV drug discovery

Published:2014-10-28 Issue:2 Volume:10 Page:111-123
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Sliva Katja¹

Affiliation:

1. Paul-Ehrlich-Institute, Department of Virology, Section 2/2 AIDS, New and Emerging pathogens, Paul-Ehrlich Strasse 51-59, 63225 Langen, Germany ; ;

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1517/17460441.2015.975201

Reference138 articles.

1. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

2. Timing the Ancestor of the HIV-1 Pandemic Strains

3. Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

4. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection

5. Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection;Bioorganic & Medicinal Chemistry;2022-08

2. Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection;Bioorganic & Medicinal Chemistry;2019-09

3. Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection;Bioorganic & Medicinal Chemistry Letters;2019-07

4. Investigation of the Pentathiepin Functionality as an Inhibitor of Feline Immunodeficiency Virus (FIV) via a Potential Zinc Ejection Mechanism, as a Model for HIV Infection;ChemMedChem;2019-01-25

5. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS;Journal of Neuroimmune Pharmacology;2018-09-13